Ricelle A. Acob
Research Subjects
Ricelle A. Acob has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andreas R. Gschwind
Department of Genetics, Stanford University School of Medicine, Stanford, USA
1 shared publication - Annique Claringbould
European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany
1 shared publication - Aruna Ayer
Waters Biosciences; Milpitas, CA, USA
1 shared publication - Benedikt Rauscher
European Molecular Biology Laboratory (EMBL), Genome Biology Unit; Heidelberg, Germany
1 shared publication - Britta Velten
Centre for Organismal Studies, Heidelberg University, Heidelberg, Germany
1 shared publication - Claudia Feng
Wellcome Sanger Institute, Wellcome Genome Campus; Hinxton, UK
1 shared publication
Latest Publications
- Open Access
Genome-scale mapping of variant, enhancer and gene function in primary human CD4+ T cells
CD4+ T cells harbor a disproportionate enrichment of immune disease risk loci and represent the primary cellular context for immune disease biology, yet the genes and regulatory programs these variants affect remain largely unknown. We combined targeted Perturb-seq of 1,032 cis -regulatory elements (CREs) overlapping 4,724 variants across 14 immune diseases with genome-wide Perturb-seq of all expressed genes in primary human CD4+ T cells, spanning 4.1 million cells. We identified 626 CRE-gene pairs, and connected CRE targets to downstream regulatory cascades. At the TYK2 and DEXI /CLEC16A loci, we resolved target genes and linked noncoding variants to inflammatory and metabolic programs. Across diseases, we revealed that dispersed variants converged on shared and disease-specific programs. Our work provides a framework for tracing variant-to-CRE-to-gene-to-network in disease-relevant primary cells.
Open AccessGenome-scale mapping of variant, enhancer and gene function in primary human CD4+ T cells
CD4+ T cells harbor a disproportionate enrichment of immune disease risk loci and represent the primary cellular context for immune disease biology, yet the genes and regulatory programs these variants affect remain largely unknown. We combined targeted Perturb-seq of 1,032 cis -regulatory elements (CREs) overlapping 4,724 variants across 14 immune diseases with genome-wide Perturb-seq of all expressed genes in primary human CD4+ T cells, spanning 4.1 million cells. We identified 626 CRE-gene pairs, and connected CRE targets to downstream regulatory cascades. At the TYK2 and DEXI /CLEC16A loci, we resolved target genes and linked noncoding variants to inflammatory and metabolic programs. Across diseases, we revealed that dispersed variants converged on shared and disease-specific programs. Our work provides a framework for tracing variant-to-CRE-to-gene-to-network in disease-relevant primary cells.